Training | 2017.03.02
Early Results Show Irregular Heartbeat Improves After Mesenchymal Stem Cells Treatment
A new study published this month in STEM CELLS Translational Medicine indicates that treating heart patients with mesenchymal stem cells (MSCs) does not increase their risk of irregular heart beat (arrhythmia). In fact, the MSCs had the opposite effect and showed promise of improving the condition.
(PRWeb March 01, 2017)
Read the full story at http://www.prweb.com/releases/2017/03/prweb14111923.htm
For more information, please visit
http://www.prweb.com/releases/2017/03/prweb14111923.htm
